U.S. markets open in 2 hours 41 minutes
  • S&P Futures

    4,461.75
    -12.50 (-0.28%)
     
  • Dow Futures

    34,672.00
    -77.00 (-0.22%)
     
  • Nasdaq Futures

    15,482.75
    -35.00 (-0.23%)
     
  • Russell 2000 Futures

    2,223.80
    -9.40 (-0.42%)
     
  • Crude Oil

    72.13
    -0.48 (-0.66%)
     
  • Gold

    1,764.50
    +7.80 (+0.44%)
     
  • Silver

    23.03
    +0.24 (+1.06%)
     
  • EUR/USD

    1.1787
    +0.0015 (+0.13%)
     
  • 10-Yr Bond

    1.3310
    0.0000 (0.00%)
     
  • Vix

    19.44
    +1.26 (+6.93%)
     
  • GBP/USD

    1.3791
    -0.0005 (-0.04%)
     
  • USD/JPY

    109.9720
    +0.2540 (+0.23%)
     
  • BTC-USD

    47,446.56
    -429.70 (-0.90%)
     
  • CMC Crypto 200

    1,205.96
    -27.33 (-2.22%)
     
  • FTSE 100

    7,012.02
    -15.46 (-0.22%)
     
  • Nikkei 225

    30,500.05
    +176.71 (+0.58%)
     

StemCells terminates mid-stage study; to wind down operations

May 31 (Reuters) - StemCells Inc said on Tuesday it had terminated a mid-stage trial in spinal cord injury and that its board had decided to wind down the company.

The decision to end the trial followed an in-depth review of data from the study and after obtaining the concurrence of the study's Interim Analysis Data Monitoring Committee, the company said.

Shares of the company, which had a market value of about $35.5 million as of Friday close, were halted before the bell.

(Reporting by Amrutha Penumudi in Bengaluru)